Ezike Tobechukwu Christian, Okpala Ugochukwu Solomon, Onoja Ufedo Lovet, Nwike Chinenye Princess, Ezeako Emmanuel Chimeh, Okpara Osinachi Juliet, Okoroafor Charles Chinkwere, Eze Shadrach Chinecherem, Kalu Onyinyechi Loveth, Odoh Evaristus Chinonso, Nwadike Ugochukwu Gideon, Ogbodo John Onyebuchi, Umeh Bravo Udochukwu, Ossai Emmanuel Chekwube, Nwanguma Bennett Chima
Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, 410001, Enugu State, Nigeria.
Department of Genetics and Biotechnology, Faculty of Biological Sciences, University of Nigeria, Nsukka, 410001, Enugu State, Nigeria.
Heliyon. 2023 Jun 24;9(6):e17488. doi: 10.1016/j.heliyon.2023.e17488. eCollection 2023 Jun.
Advances in molecular pharmacology and an improved understanding of the mechanism of most diseases have created the need to specifically target the cells involved in the initiation and progression of diseases. This is especially true for most life-threatening diseases requiring therapeutic agents which have numerous side effects, thus requiring accurate tissue targeting to minimize systemic exposure. Recent drug delivery systems (DDS) are formulated using advanced technology to accelerate systemic drug delivery to the specific target site, maximizing therapeutic efficacy and minimizing off-target accumulation in the body. As a result, they play an important role in disease management and treatment. Recent DDS offer greater advantages when compared to conventional drug delivery systems due to their enhanced performance, automation, precision, and efficacy. They are made of nanomaterials or miniaturized devices with multifunctional components that are biocompatible, biodegradable, and have high viscoelasticity with an extended circulating half-life. This review, therefore, provides a comprehensive insight into the history and technological advancement of drug delivery systems. It updates the most recent drug delivery systems, their therapeutic applications, challenges associated with their use, and future directions for improved performance and use.
分子药理学的进展以及对大多数疾病发病机制的深入理解,使得人们需要特异性地靶向参与疾病起始和进展的细胞。对于大多数危及生命的疾病而言尤其如此,这些疾病需要使用具有众多副作用的治疗药物,因此需要精确的组织靶向以尽量减少全身暴露。最近的药物递送系统(DDS)采用先进技术来加速全身药物递送至特定靶位点,从而使治疗效果最大化并使体内非靶标累积最小化。因此,它们在疾病管理和治疗中发挥着重要作用。与传统药物递送系统相比,最近的DDS具有更大的优势,因为它们具有更高的性能、自动化程度、精准度和疗效。它们由纳米材料或具有多功能组件的小型化装置制成,这些组件具有生物相容性、可生物降解性,并且具有高粘弹性和延长的循环半衰期。因此,本综述全面深入地探讨了药物递送系统的历史和技术进步。它更新了最新的药物递送系统、它们的治疗应用、与使用相关的挑战以及提高性能和应用的未来方向。